본문 바로가기
KERD
논문KCI 등재

일 대학병원 정신과 외래를 방문한 우울증 환자에서의 하지불안증후군

Restless Legs Syndrome in Depressed Psychiatric Outpatients

사공정규|곽경필|이광헌|원승희|박창증|손용표|한영훈|이도윤
대한생물치료정신의학회 (Korean Society Of Biological Therapies In Psychiatry)|2011.06|생물치료정신의학 (Journal of the Korean Society of Biological Therapies in Psychiatry)|제17권 제1호|pp. 38-46

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

하지불안증후군·우울증·항우울제·삶의 질·수면의 질RLS · Depression · Antidepressant · Sleep quality · Quality of life
주제분류정신과학

초록

Objectives：This study was designed to investigate the clinical characteristics, relationship with antidepressants and incidence of restless legs syndrome(RLS) in depressed outpatients. Methods：Total 160 adult patients(male 32, female 128) of psychiatric outpatient were enrolled in this study. We use the diagnostic criteria of International RLS Study Group(IRLSSG) for RLS. Also WHO quality of life scale abbreviated version(WHOQOL-BREF), Hamilton Depression Rating Scale-17(HAM-D) and Pittsburgh Sleep Quality Index(PSQI) was used to investigate the relationship between RLS and depression severity, quality of life, sleep quality. Results：In 39(24.4%) out of the total 160 patients were diagnosed as having RLS. Among those 39 RLS patient, 19 patients(48.7%) was reported to have developed their RLS after starting depression treatment. The RLS group showed higher PSQI and HAM-D scores(p=0.02, p＜0.01) and lower WHOQOL-BREF score(p=0.06) compared to those of non-RLS. Compared to those of non-RLS group, the bupropion group showed a significantly low rate of RLS group (p=0.043) and the venlafaxine group showed a significantly high rate of RLS group(p=0.018). HAM-D score 7 or more group caused RLS 4.5 times compared those of less than HAM-D score 7 group. Conclusion：In this study, depressed outpatients showed high incidence rate of RLS and RLS had influence on sleep quality, depression severity and quality of life. Moreover, certain antidepressants had potential to induce RLS. Therefore, these results suggest that appropriate treatment for depression is required to clinicians and development of RLS from depressed patients should be carefully monitored. Further research about the relationship between antidepressant and RLS is also necessary.

Abstract

Objectives：This study was designed to investigate the clinical characteristics, relationship with antidepressants and incidence of restless legs syndrome(RLS) in depressed outpatients. Methods：Total 160 adult patients(male 32, female 128) of psychiatric outpatient were enrolled in this study. We use the diagnostic criteria of International RLS Study Group(IRLSSG) for RLS. Also WHO quality of life scale abbreviated version(WHOQOL-BREF), Hamilton Depression Rating Scale-17(HAM-D) and Pittsburgh Sleep Quality Index(PSQI) was used to investigate the relationship between RLS and depression severity, quality of life, sleep quality. Results：In 39(24.4%) out of the total 160 patients were diagnosed as having RLS. Among those 39 RLS patient, 19 patients(48.7%) was reported to have developed their RLS after starting depression treatment. The RLS group showed higher PSQI and HAM-D scores(p=0.02, p＜0.01) and lower WHOQOL-BREF score(p=0.06) compared to those of non-RLS. Compared to those of non-RLS group, the bupropion group showed a significantly low rate of RLS group (p=0.043) and the venlafaxine group showed a significantly high rate of RLS group(p=0.018). HAM-D score 7 or more group caused RLS 4.5 times compared those of less than HAM-D score 7 group. Conclusion：In this study, depressed outpatients showed high incidence rate of RLS and RLS had influence on sleep quality, depression severity and quality of life. Moreover, certain antidepressants had potential to induce RLS. Therefore, these results suggest that appropriate treatment for depression is required to clinicians and development of RLS from depressed patients should be carefully monitored. Further research about the relationship between antidepressant and RLS is also necessary.

참고문헌 (43)

  1. Ekbom K, "Restless legs", Acta Med Scand, 158, pp.1~123 (1945)
  2. Allen RP, "Restless legs syndrome:diagnostic criteria,special considerations,and epidemiology,A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health", Sleep Med, 4, pp.101~119 (2003)
  3. Yun CH, "Pathophysiology of the restless legs syndrome:dopamine and iron", J Kor Sleep Soc, 3, pp.22~28 (2006)
  4. Ondo W, "Restless legs syndrome:clinicoetiologic correlates", Neurology, 47, pp.1435~1441 (1996)
  5. Rutkove SB, "Restless legs syndrome in patients with polyneuropathy", Muscle Nerve, 19, pp.670~672 (1996)
  6. Sanz-Fuentenebro FJ, "Restless legs syndrome and paroxetine", Acta Psychiatr Scand, 94, pp.482~484 (1996)
  7. 최현석, "혈 액 투석을 받는 만성 신부전 환자에서 하지불안증후 군과 삶의 질", 수면·정신생리, 14, pp.99~106 (2007)
  8. Tison F, "Epidemiology of restless legs syndrome in French adults:a nationwide survey:the INSTANT Study", Neurology, 65, pp.239~246 (2005)
  9. Hogl B, "Restless legs syndrome:a community-based study of prevalence,severity,and risk factors", Neurology, 64, pp.1920~1924 (2005)
  10. Bjorvatn B, "Prevalence,severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries", Sleep Med, 6, pp.307~12 (2005)
  11. Hening W, "Impact,diagnosis and treatment of restless legs syndrome(RLS)in a primary care population:the REST(RLS epidemiology,symptoms,and treatment)primary care study", Sleep Med, 5, pp.237~246 (2004)
  12. Rothdach AJ, "Prevalence and risk factors of RLS in an elderly population:the MEMO study.Memory and Morbidity in Augsburg Elderly", Neurology, 54, pp.1064~1068 (2000)
  13. Allen RP, "Restless legs syndrome prevalence and impact:REST general population study", Arch Intern Med, 165, pp.1286~1292 (2005)
  14. Berger K, "Sex and the risk of restless legs syndrome in the general population", Arch Intern Med, 164, pp.196~202 (2004)
  15. Cho YW, "Epidemiology of restless legs syndrome in Korean adults", SLEEP, 31(2), pp.219~223, AMER ACAD SLEEP MEDICINE
  16. Nichols DA, "Restless legs syndrome symptoms in primary care:a prevalence study", Arch Intern Med, 163, pp.2323~2329 (2003)
  17. 함병주, "하지불편 증후군과 주기성 사지운동장애의 진단과 치료", 수면·정신생리, 10, pp.26~31 (2003)
  18. Banno K, "Restless legs syndrome in 218 patients:associated disorders", Sleep Med, 1, pp.221~229 (2000)
  19. Phillips KD, "Sleep disturbance and depression as barriers to adherence", Clin Nurs Res, 14, pp.273~293 (2005)
  20. "2003", 10
  21. Reimer MA, "Quality of life in sleep disorders", Sleep Med Rev, 7, pp.335~349 (2003)
  22. Hargrave R, "Restless leg syndrome exacerbated by sertraline", Psychosomatics, 39, pp.177~178 (1998)
  23. Bakshi R, "Fluoxetine and restless legs syndrome", J Neurol Sci, 142, pp.151~152 (1996)
  24. Perroud N, "Restless legs syndrome induced by citalopram: a psychiatric emergency", Gen Hosp Psychiatry, 29, pp.72~74 (2007)
  25. Agargun MY, "Restless legs syndrome induced by mirtazapine", J Clin Psychiatry, 63, pp.1179~ (2002)
  26. Bonin B, "Mirtazapine and restless leg syndrome:a case report", Therapie, 55, pp.655~656 (2000)
  27. Chang CC, "Does domperidone potentiate mirtazapine-associated restless legs syndrome", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.316~318 (2006)
  28. 배치운, "Re-administration of mirtazapine could overcome previous mirtazapine-associated restless legs syndrome?", PSYCHIATRY AND CLINICAL NEUROSCIENCES, 58, pp.669~670, BLACKWELL PUBLISHING
  29. Teive HA, "Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report", Arq Neuropsiquiatr, 60, pp.1025~1029 (2002)
  30. 배치운, "Mirtazapine may have the propensity for developing a restless legs syndrome? A case report", PSYCHIATRY AND CLINICAL NEUROSCIENCES, 56, pp.209~210 (2002), BLACKWELL PUBLISHING
  31. Brown LK, "Antidepressant medication use and restless legs syndrome in patients presenting with insomnia", Sleep Med, 6, pp.443~450 (2005)
  32. Ohayon MM, "Prevalence of restless legs syndrome and periodic limb movement disorder in the general population", J Psychosom Res, 53, pp.547~554 (2002)
  33. Rottach KG, "Restless legs syndrome as side effect of second generation antidepressants", J Psychiatr Res, 43, pp.70~75 (2008)
  34. 우정민, "하지불안증후군과 정신과 약물", 수면·정신생리, 17, pp.5~10 (2010)
  35. Buysse DJ, "The Pittsburgh Sleep Quality Index:a new instrument for psychiatric practice and research", Psychiatry Res, 28, pp.193~213 (1989)
  36. Min SK, "Development of the Korean versions of WHO Quality of Life scale and WHOQOL-BREF", Qual Life Res, 11, pp.593~600 (2002)
  37. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
  38. Picchietti D, "Restless legs syndrome,periodic limb movements in sleep,and depression", Sleep, 28, pp.891~898 (2005)
  39. 지구덕, "정신과 외래에서 향정신성약물을 복용 중인 환자에서의 하지불편증후군", 신경정신의학, 46(4), pp.391~397 (2007), 대한신경정신의학회
  40. Hornyak M, "Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome", J Clin Psychiatry, 66, pp.1139~1145 (2005)
  41. Kim SW, "Bupropion may improve restless legs syndrome:a report of three cases", Clin Neuropharmacol, 28, pp.298~301 (2005)
  42. Lee JJ, "Bupropion as a possible treatment option for restless legs syndrome", Ann Pharmacother, 43, pp.370~374 (2009)
  43. Salin-Pascual RJ, "Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers", J Clin Psychiatry, 58, pp.348~350 (1997)

이 간행물의 다른 논문 (15건)

중독환자에서 보이는 사회인지의 손상김양태pp. 5-10청소년기 뇌 발달과 인지, 행동 특성박재홍, 김성환pp. 11-20Comparison of Effectiveness between Aripiprazole and Risperidone for Treating Delirium in Hospitalized Patients정성원, 사공정규, 한영훈pp. 21-29알쯔하이머형 치매에서 한국판 보스톤 이름대기검사와 지연회상검사 조합의 진단적 유용성구본훈, 김진성, 이준엽, 이종범, 차영pp. 30-37공황장애환자의 기질 및 성격에 따른 임상표현양상장문선, 박영우, 최상용, 신연주, 곽호완, 배대석pp. 47-54
원문 보기